Substantial Innovate UK grant awarded to broaden neurodegenerative disease models in collaboration with Oxford University

Chronos Therapeutics together with Prof Alison Woollard, of the Department of Biochemistry at the University of Oxford, has been successful in securing a substantial grant award from the UK’s Innovation Agency, Innovate UK.